In the News: Australia’s First Cell-Based Influenza Vaccine Hits the Market
https://ajp.com.au/news/from-eggs-to-cells/ AusTrials is currently recruiting for an influenza vaccine study comparing the Flucelvax Quad vaccine (developed utilising the revolutionary technology talked about in this article) to another new vaccine, also developed with this technology but with an added agent to enhance the immune response. The purpose of this study is to measure this response…
